Financial statements Inspire Pharma
Balance sheet data of INSPIRE PHARMA
|
Year
|
2017
|
2018
|
2019
|
2020
|
2022
|
|---|---|---|---|---|---|
| Total assets | 3 125,00 | 151 695,90 | 454 790,53 | 1 669 909,11 | 87 593,31 |
| A. Fixed assets | 0,00 | 0,00 | 28 462,24 | 27 054,76 | 27 054,76 |
| B. Current assets | 3 125,00 | 151 695,90 | 426 328,29 | 1 642 854,35 | 60 538,55 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 3 125,00 | 151 695,90 | 454 790,53 | 1 669 909,11 | 87 593,31 |
| A. Equity | 3 125,00 | 3 279,43 | -190 510,35 | -238 899,63 | -690 884,26 |
| B. Liabilities and provisions for liabilities | 0,00 | 148 416,47 | 645 300,88 | 1 908 808,74 | 778 477,57 |
| I. Long-term liabilities | 0,00 | 25 000,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 0,00 | 123 416,47 | 645 300,88 | 1 908 808,74 | 778 477,57 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.